Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors-Reference-Cited by-同舟云学术

Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors

Published:2018-12-31 Issue:6 Volume:12 Page:537-552
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Peng Yanmei¹,Li Qiang¹,Zhang Jingyi¹,Shen Wen¹,Zhang Xu¹,Sun Chenyao¹,Cui Huijuan²

Affiliation:

1. Beijing University of Chinese Medicine, China-Japan Friendship Hospital

2. Department of Integrative Oncology, China-Japan Friendship Hospital

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health(social science)

Link

https://www.jstage.jst.go.jp/article/bst/12/6/12_2018.01246/_pdf

Reference158 articles.

1. 1. Mok TS, Wu YL, Thongprasert s, et al. Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma. N Engl J Med. 2009; 361:947-957.

2. 2. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Head and Neck Cancers. https://www.nccn.org/professionals/physician_gls/default.aspx (accessed September 14, 2018).

3. 3. Tischer B, Huber R, Kraemer M, Lacouture ME. Dermatologic events from EGFR inhibitors: The issue of the missing patient voice. Support Care Cancer, 2017; 25:651-660.

4. 4. Patil VM, Noronha V, Joshi A, et al. Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma. ESMO Open. 2017; 2:e000168.

5. 5. Burtness B, Anadkat M, Basti S, Hughes M, Lacouture ME, McClure JS, Myskowski PL, Paul J, Perlis CS, Saltz L, Spencer S. NCCN Task Force Report: Management of Dermatologic and Other Toxicities Associated With EGFR Inhibition in Patients With Cancer. J Natl Compr Canc Netw. 2009; 71:S5-S21.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience;Journal of the Formosan Medical Association;2024-08

2. Cutaneous adverse events following treatment with third-generation EGFR tyrosine kinase inhibitors;Italian Journal of Dermatology and Venereology;2024-04

3. Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity;World Journal of Oncology;2024-04

4. Dermatologic toxicities in epidermal growth factor receptor: a comprehensive pharmacovigilance study from 2013 to 2023;Frontiers in Medicine;2024-01-24

5. Ectrodactylia, ectodermalis dysplasia, ajak- és szájpadhasadék szindróma;Orvosi Hetilap;2023-11-19